{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:12:13Z","timestamp":1787850733774,"version":"build-2784847793"},"reference-count":104,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":519,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1124\/dmd.122.001005","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T17:00:32Z","timestamp":1686157232000},"page":"923-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Translating Kratom-Drug Interactions: From Bedside to Bench and Back"],"prefix":"10.1016","volume":"51","author":[{"given":"Rakshit S.","family":"Tanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja B.","family":"Cech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas H.","family":"Oberlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan E.","family":"Rettie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth E.","family":"Thummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3331-1839","authenticated-orcid":false,"given":"Mary F.","family":"Paine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.001005_bib1","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/molecules23102696","article-title":"Inhibition of UGT2B7 enzyme activity in human and rat liver microsomes by herbal constituents","volume":"23","author":"Abdullah","year":"2018","journal-title":"Molecules"},{"key":"10.1124\/dmd.122.001005_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40138-019-00194-1","article-title":"Kratom from head to toe\u2014case reviews of adverse events and toxicities","volume":"7","author":"Alsarraf","year":"2019","journal-title":"Curr Emerg Hosp Med Rep"},{"key":"10.1124\/dmd.122.001005_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/pm\/pnab126","article-title":"The addictive potential and challenges with use of the \u201cherbal supplement\u201d kratom: a case report and literature review","volume":"23","author":"Anand","year":"2022","journal-title":"Pain Med"},{"key":"10.1124\/dmd.122.001005_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1055\/a-0770-3683","article-title":"Comparative pharmacokinetics of mitragynine after oral administration of Mitragyna speciosa (kratom) leaf extracts in rats","volume":"85","author":"Avery","year":"2019","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jchromb.2018.02.010","article-title":"Identification of five Mitragyna alkaloids in urine using liquid chromatography-quadrupole\/time of flight mass spectrometry","volume":"1080","author":"Basiliere","year":"2018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/dmd.122.001005_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jat\/bkz103","article-title":"Temperature and pH-dependent stability of Mitragyna alkaloids","volume":"44","author":"Basiliere","year":"2020","journal-title":"J Anal Toxicol"},{"key":"10.1124\/dmd.122.001005_bib7","doi-asserted-by":"crossref","first-page":"162S","DOI":"10.1111\/j.2042-7158.1969.tb08368.x","article-title":"The influence of stereochemistry on pKa, rate of quaternization and partition coefficients of corynantheidine-type alkaloids","volume":"21","author":"Beckett","year":"1969","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113778","article-title":"Preclinical pharmacokinetic study of speciociliatine, a kratom alkaloid, in rats using an UPLC-MS\/MS method","volume":"194","author":"Berthold","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.122.001005_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/dmd.121.000640","article-title":"The lack of contribution of 7-hydroxymitragynine to the antinociceptive effects of mitragynine in mice: a pharmacokinetic and pharmacodynamic study","volume":"50","author":"Berthold","year":"2022","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001005_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0024-3205(02)01680-6","article-title":"In vitro P-glycoprotein affinity for atypical and conventional antipsychotics","volume":"71","author":"Boulton","year":"2002","journal-title":"Life Sci"},{"key":"10.1124\/dmd.122.001005_bib11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1360-0443.2008.02209.x","article-title":"Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa korth)","volume":"103","author":"Boyer","year":"2008","journal-title":"Addiction"},{"key":"10.1124\/dmd.122.001005_bib12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/ADM.0000000000000968","article-title":"A case of potential pharmacokinetic kratom-drug interactions resulting in toxicity and subsequent treatment of kratom use disorder with buprenorphine\/naloxone","volume":"16","author":"Brogdon","year":"2022","journal-title":"J Addict Med"},{"key":"10.1124\/dmd.122.001005_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jep.2017.03.020","article-title":"A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: implications for products sold as kratom","volume":"202","author":"Brown","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.122.001005_bib14","doi-asserted-by":"crossref","first-page":"16553","DOI":"10.1021\/acs.jmedchem.1c01111","article-title":"Oxidative metabolism as a modulator of kratom\u2019s biological actions","volume":"64","author":"Chakraborty","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.122.001005_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acs.jnatprod.0c01055","article-title":"Exploring the chemistry of alkaloids from Malaysian Mitragyna speciosa (kratom) and the role of oxindoles on human opioid receptors","volume":"84","author":"Chear","year":"2021","journal-title":"J Nat Prod"},{"key":"10.1124\/dmd.122.001005_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2174\/1389450118666170925154025","article-title":"A review on the antinociceptive effects of Mitragyna speciosa and its derivatives on animal model","volume":"19","author":"Chin","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1124\/dmd.122.001005_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/968786","article-title":"Following \u201cthe roots\u201d of kratom (Mitragyna speciosa): the evolution of an enhancer from a traditional use to increase work and productivity in Southeast Asia to a recreational psychoactive drug in western countries","volume":"2015","author":"Cinosi","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1124\/dmd.122.001005_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2019.05.005","article-title":"Kratom as a substitute for opioids: results from an online survey","volume":"202","author":"Coe","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/dmd.122.001005_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1177\/0269881119862530","article-title":"Characteristics of deaths associated with kratom use","volume":"33","author":"Corkery","year":"2019","journal-title":"J Psychopharmacol"},{"key":"10.1124\/dmd.122.001005_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/cts.13172","article-title":"Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: a NaPDI Center recommended approach","volume":"15","author":"Cox","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.122.001005_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1124\/pharmrev.120.000106","article-title":"Modeling pharmacokinetic natural product-drug interactions for decision-making: a NaPDI Center recommended approach","volume":"73","author":"Cox","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.122.001005_bib22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/phar.2280","article-title":"Kratom use and toxicities in the United States","volume":"39","author":"Eggleston","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1124\/dmd.122.001005_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/CT9211900887","article-title":"XCVIII.\u2014Mitragynine and mitraversine, two new alkaloids from species of mitragyne","volume":"119","author":"Field","year":"1921","journal-title":"J Chem Soc Trans"},{"key":"10.1124\/dmd.122.001005_bib24","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acs.jnatprod.0c00257","article-title":"The chemistry of kratom [Mitragyna speciosa]: updated characterization data and methods to elucidate indole and oxindole alkaloids","volume":"83","author":"Flores-Bocanegra","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1124\/dmd.122.001005_bib25","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1111\/bcp.13341","article-title":"4\u03b2-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients","volume":"83","author":"Gjestad","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2022.101442","article-title":"Kratom: history, pharmacology, current user trends, adverse health effects and potential benefits","volume":"69","author":"Grundmann","year":"2023","journal-title":"Dis Mon"},{"key":"10.1124\/dmd.122.001005_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0974-8490.118806","article-title":"Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities","volume":"5","author":"Hanapi","year":"2013","journal-title":"Pharmacognosy Res"},{"key":"10.1124\/dmd.122.001005_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jep.2010.07.013","article-title":"Acute toxicity study of the standardized methanolic extract of Mitragyna speciosa Korth in rodent","volume":"131","author":"Harizal","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.122.001005_bib29","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jcph.2001","article-title":"Clinical pharmacology of the dietary supplement kratom (Mitragyna speciosa)","volume":"62","author":"Hartley","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neubiorev.2012.11.012","article-title":"From kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction","volume":"37","author":"Hassan","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/dmd.122.001005_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.apha.2021.10.001","article-title":"In vitro and in vivo pharmacology of kratom","volume":"93","author":"Hiranita","year":"2022","journal-title":"Adv Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/anatox\/35.1.54","article-title":"A drug toxicity death involving propylhexedrine and mitragynine","volume":"35","author":"Holler","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1124\/dmd.122.001005_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s12024-018-0049-9","article-title":"Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction","volume":"15","author":"Hughes","year":"2019","journal-title":"Forensic Sci Med Pathol"},{"key":"10.1124\/dmd.122.001005_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/FBP.0000000000000715","article-title":"Mitragynine, a primary constituent of kratom reinstates morphine-seeking behaviour in rats","volume":"34","author":"Japarin","year":"2023","journal-title":"Behav Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib35","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acsptsci.0c00075","article-title":"Metabolism of a kratom alkaloid metabolite in human plasma increases its opioid potency and efficacy","volume":"3","author":"Kamble","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1124\/dmd.122.001005_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxlet.2019.11.005","article-title":"Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids","volume":"319","author":"Kamble","year":"2020","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.122.001005_bib37","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1080\/00498254.2018.1552819","article-title":"Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom)","volume":"49","author":"Kamble","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.122.001005_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.805986","article-title":"The chemical and pharmacological properties of mitragynine and its diastereomers: an insight review","volume":"13","author":"Karunakaran","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib39","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1039\/C8NP00065D","article-title":"Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach","volume":"36","author":"Kellogg","year":"2019","journal-title":"Nat Prod Rep"},{"key":"10.1124\/dmd.122.001005_bib40","article-title":"Kratom: a systematic review of toxicological issues","volume":"4","author":"Kerrigan","year":"2022","journal-title":"Wiley Interdisciplinary Reviews: Forensic Science"},{"key":"10.1124\/dmd.122.001005_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2174\/1386207320666171026121820","article-title":"Physicochemical characterization of Mitragyna speciosa alkaloid extract and mitragynine using in vitro high throughput assays","volume":"20","author":"Kong","year":"2017","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1124\/dmd.122.001005_bib42","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.3390\/molecules16097344","article-title":"Evaluation of the effects of Mitragyna speciosa alkaloid extract on cytochrome P450 enzymes using a high throughput assay","volume":"16","author":"Kong","year":"2011","journal-title":"Molecules"},{"key":"10.1124\/dmd.122.001005_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/anatox\/35.4.242","article-title":"Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton","volume":"35","author":"Kronstrand","year":"2011","journal-title":"J Anal Toxicol"},{"key":"10.1124\/dmd.122.001005_bib44","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1021\/jacs.6b00360","article-title":"Synthetic and receptor signaling explorations of the Mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators","volume":"138","author":"Kruegel","year":"2016","journal-title":"J Am Chem Soc"},{"issue":"Pt A","key":"10.1124\/dmd.122.001005_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.122.001005_bib46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1021\/acscentsci.9b00141","article-title":"7-Hydroxymitragynine is an active metabolite of mitragynine and a key mediator of its analgesic effects","volume":"5","author":"Kruegel","year":"2019","journal-title":"ACS Cent Sci"},{"key":"10.1124\/dmd.122.001005_bib47","doi-asserted-by":"crossref","first-page":"13510","DOI":"10.1021\/acs.jmedchem.1c00726","article-title":"Activity of Mitragyna speciosa (\u201ckratom\u201d) alkaloids at serotonin receptors","volume":"64","author":"Le\u00f3n","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.122.001005_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13505","article-title":"An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021","author":"Li","year":"2023","journal-title":"Clin Transl Sci."},{"key":"10.1124\/dmd.122.001005_bib49","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.3390\/molecules26185500","article-title":"Endogenous biomarkers for SLC transporter-mediated drug-drug interaction evaluation","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1124\/dmd.122.001005_bib50","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.tiv.2012.12.014","article-title":"In vitro evaluation of cytochrome P450 induction and the inhibition potential of mitragynine, a stimulant alkaloid","volume":"27","author":"Lim","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.122.001005_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s13181-016-0588-y","article-title":"Suspected adulteration of commercial kratom products with 7-hydroxymitragynine","volume":"12","author":"Lydecker","year":"2016","journal-title":"J Med Toxicol"},{"key":"10.1124\/dmd.122.001005_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bod.2510090602","article-title":"The potential role of lysosomes in tissue distribution of weak bases","volume":"9","author":"MacIntyre","year":"1988","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.122.001005_bib53","doi-asserted-by":"crossref","DOI":"10.1055\/s-0034-1382760","article-title":"Determination of ADME properties of mitragynine, 7-hydroxymitragynine, and mitraphylline","volume":"80","author":"Manda","year":"2014","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib54","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0034-1382760","article-title":"Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline","volume":"80","author":"Manda","year":"2014","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib55","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/ptr.5942","article-title":"PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids","volume":"31","author":"Manda","year":"2017","journal-title":"Phytother Res"},{"key":"10.1124\/dmd.122.001005_bib56","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1055\/a-1795-5876","article-title":"Kratom (Mitragyna speciosa) validation: quantitative analysis of indole and oxindole alkaloids reveals chemotypes of plants and products","volume":"88","author":"Manwill","year":"2022","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(96)00714-5","article-title":"Central antinociceptive effects of mitragynine in mice: contribution of descending noradrenergic and serotonergic systems","volume":"317","author":"Matsumoto","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib58","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/0024-3205(96)00432-8","article-title":"Antinociceptive action of mitragynine in mice: evidence for the involvement of supraspinal opioid receptors","volume":"59","author":"Matsumoto","year":"1996","journal-title":"Life Sci"},{"key":"10.1124\/dmd.122.001005_bib59","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1055\/a-1212-5475","article-title":"Pharmacokinetics and safety of mitragynine in beagle dogs","volume":"86","author":"Maxwell","year":"2020","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.049","article-title":"Opioid metabolism and clinical aspects","volume":"769","author":"Mercadante","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2014.10.026","article-title":"Contribution of human esterases to the metabolism of selected drugs of abuse","volume":"232","author":"Meyer","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.122.001005_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20531\/tfb.2022.50.1.03","article-title":"Additional knowledge on the genus Mitragyna (Rubiaceae) in Thailand","volume":"50","author":"Ngernsaengsaruay","year":"2022","journal-title":"Thai Forest Bulletin (Botany)"},{"key":"10.1124\/dmd.122.001005_bib63","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/cpt.2107","article-title":"Assessing transporter-mediated natural product-drug interactions via in vitro-in vivo extrapolation: clinical evaluation with a probe cocktail","volume":"109","author":"Nguyen","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001005_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acs.jmedchem.9b01465","article-title":"Investigation of the adrenergic and opioid binding affinities, metabolic stability, plasma protein binding properties, and functional effects of selected indole-based kratom alkaloids","volume":"63","author":"Obeng","year":"2020","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.122.001005_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.120.000189","article-title":"Pharmacological comparison of mitragynine and 7-hydroxymitragynine: in vitro affinity and efficacy for \u03bc-opioid receptor and opioid-like behavioral effects in rats","volume":"376","author":"Obeng","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001005_bib66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/dmd.120.000182","article-title":"Natural products: experimental approaches to elucidate disposition mechanisms and predict pharmacokinetic drug interactions","volume":"48","author":"Paine","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001005_bib67","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/cpt.1168","article-title":"\u201cGreen medicine\u201d: the past, present, and future of botanicals","volume":"104","author":"Paine","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001005_bib68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jat\/bkz064","article-title":"The trouble with kratom: analytical and interpretative issues involving mitragynine","volume":"43","author":"Papsun","year":"2019","journal-title":"J Anal Toxicol"},{"key":"10.1124\/dmd.122.001005_bib69","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00216-010-3707-7","article-title":"Determination of mitragynine in plasma with solid-phase extraction and rapid HPLC-UV analysis, and its application to a pharmacokinetic study in rat","volume":"397","author":"Parthasarathy","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.122.001005_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107054","article-title":"Mitragyna speciosa (kratom) poisoning: findings from ten cases","volume":"225","author":"Peran","year":"2023","journal-title":"Toxicon"},{"key":"10.1124\/dmd.122.001005_bib71","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/jms.1607","article-title":"Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry","volume":"44","author":"Philipp","year":"2009","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.122.001005_bib72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2006-959578","article-title":"A new indole alkaloid, 7 alpha-hydroxy-7H-mitragynine, from Mitragyna speciosa in Thailand","volume":"60","author":"Ponglux","year":"1994","journal-title":"Planta Med"},{"key":"10.1124\/dmd.122.001005_bib73","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/15563650.2019.1569236","article-title":"Kratom exposures reported to United States poison control centers: 2011-2017","volume":"57","author":"Post","year":"2019","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1124\/dmd.122.001005_bib74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2019.05.003","article-title":"Kratom policy: the challenge of balancing therapeutic potential with public safety","volume":"70","author":"Prozialeck","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1124\/dmd.122.001005_bib75","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J Am Osteopath Assoc"},{"key":"10.1124\/dmd.122.001005_bib76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-12-819487-4.00003-3","article-title":"Kratom (Mitragyna speciosa Korth.): a description on the ethnobotany, alkaloid chemistry, and neuropharmacology","volume":"69","author":"Ramanathan","year":"2021","journal-title":"Stud Nat Prod Chem"},{"key":"10.1124\/dmd.122.001005_bib77","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.3390\/molecules20034915","article-title":"Understanding the physicochemical properties of mitragynine, a principal alkaloid of Mitragyna speciosa, for preclinical evaluation","volume":"20","author":"Ramanathan","year":"2015","journal-title":"Molecules"},{"key":"10.1124\/dmd.122.001005_bib78","first-page":"39","article-title":"Effects of the extracts from Mitragyna speciosa Korth. leaves on analgesic and behavioral activities in experimental animals","volume":"29","author":"Reanmongkol","year":"2007","journal-title":"Songklanakarin J Sci Technol"},{"key":"10.1124\/dmd.122.001005_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00210-018-01605-y","article-title":"The inhibitory effects of mitragynine on P-glycoprotein in vitro","volume":"392","author":"Rusli","year":"2019","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ddr.21052","article-title":"Dose\u2013response relationship, acute toxicity, and therapeutic index between the alkaloid extract of Mitragyna speciosa and its main active compound mitragynine in mice","volume":"74","author":"Sabetghadam","year":"2013","journal-title":"Drug Dev Res"},{"key":"10.1124\/dmd.122.001005_bib81","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jep.2013.02.008","article-title":"Subchronic exposure to mitragynine, the principal alkaloid of Mitragyna speciosa, in rats","volume":"146","author":"Sabetghadam","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1124\/dmd.122.001005_bib82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/add.15082","article-title":"Prevalence and description of kratom (Mitragyna speciosa) use in the United States: a cross-sectional study","volume":"116","author":"Schimmel","year":"2021","journal-title":"Addiction"},{"key":"10.1124\/dmd.122.001005_bib83","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40265-019-01242-6","article-title":"Kratom (Mitragyna speciosa) liver injury: a comprehensive review","volume":"80","author":"Schimmel","year":"2020","journal-title":"Drugs"},{"key":"10.1124\/dmd.122.001005_bib84","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/plants12040949","article-title":"Seasonal and geographic variation in alkaloid content of kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand","volume":"12","author":"Sengnon","year":"2023","journal-title":"Plants"},{"key":"10.1124\/dmd.122.001005_bib85","doi-asserted-by":"crossref","first-page":"26032","DOI":"10.4088\/PCC.20r02770","article-title":"Kratom: an emerging issue and need for regulations in the United States","volume":"23","author":"Shah","year":"2021","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1124\/dmd.122.001005_bib86","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/02791072.2015.1012610","article-title":"Social functioning of kratom (Mitragyna speciosa) users in Malaysia","volume":"47","author":"Singh","year":"2015","journal-title":"J Psychoactive Drugs"},{"key":"10.1124\/dmd.122.001005_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2582","article-title":"Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia","volume":"32","author":"Singh","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"10.1124\/dmd.122.001005_bib88","first-page":"21","article-title":"A study of kratom eaters in Thailand","volume":"27","author":"Suwanlert","year":"1975","journal-title":"Bull Narc"},{"key":"10.1124\/dmd.122.001005_bib89","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1248\/cpb.52.916","article-title":"Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa","volume":"52","author":"Takayama","year":"2004","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1124\/dmd.122.001005_bib90","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/pharmaceutics14030620","article-title":"Clinical pharmacokinetic assessment of kratom (Mitragyna speciosa), a botanical product with opioid-like effects, in healthy adult participants","volume":"14","author":"Tanna","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1124\/dmd.122.001005_bib91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.120.000270","article-title":"Refined prediction of pharmacokinetic kratom-drug interactions: time-dependent inhibition considerations","volume":"376","author":"Tanna","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001005_bib92","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1211\/jpp.61.05.0002","article-title":"Cytochrome P450-mediated metabolism in the human gut wall","volume":"61","author":"Thelen","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.122.001005_bib93","doi-asserted-by":"crossref","first-page":"19158","DOI":"10.1038\/s41598-020-76119-w","article-title":"Chemical composition and biological effects of kratom (Mitragyna speciosa): in vitro studies with implications for efficacy and drug interactions","volume":"10","author":"Todd","year":"2020","journal-title":"Sci Rep"},{"key":"10.1124\/dmd.122.001005_bib94","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.122.001005_bib95","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0040-4020(67)85052-X","article-title":"The absolute configuration of paynantheine and hirsutine","volume":"23","author":"Trager","year":"1967","journal-title":"Tetrahedron"},{"key":"10.1124\/dmd.122.001005_bib96","first-page":"2421","article-title":"Pharmacokinetics of mitragynine in man","volume":"9","author":"Trakulsrichai","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1124\/dmd.122.001005_bib97","article-title":"Amitriptyline dependence and its associations: a case report and literature review","volume":"2021","author":"Umaharan","year":"2021","journal-title":"Case Rep Psychiatry"},{"key":"10.1124\/dmd.122.001005_bib98","first-page":"229","article-title":"Kratom and pain tolerance: a randomized, placebo-controlled, double-blind study","volume":"93","author":"Vicknasingam","year":"2020","journal-title":"Yale J Biol Med"},{"key":"10.1124\/dmd.122.001005_bib99","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1007\/s00204-018-2276-y","article-title":"Inhibition and stimulation of the human breast cancer resistance protein as in vitro predictor of drug-drug interactions of drugs of abuse","volume":"92","author":"Wagmann","year":"2018","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.122.001005_bib100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"Int J Legal Med"},{"key":"10.1124\/dmd.122.001005_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/ADM.0000000000000721","article-title":"Treatment of kratom withdrawal and dependence with buprenorphine\/naloxone: a case series and systematic literature review","volume":"15","author":"Weiss","year":"2021","journal-title":"J Addict Med"},{"key":"10.1124\/dmd.122.001005_bib102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2146\/ajhp161035","article-title":"Pharmacologic and clinical assessment of kratom","volume":"75","author":"White","year":"2018","journal-title":"Am J Health Syst Pharm"},{"key":"10.1124\/dmd.122.001005_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102715","article-title":"The internet market for kratom, an opioid alternative and variably legal recreational drug","volume":"78","author":"Williams","year":"2020","journal-title":"Int J Drug Policy"},{"key":"10.1124\/dmd.122.001005_bib104","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/adb.12661","article-title":"Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies","volume":"24","author":"Yusof","year":"2019","journal-title":"Addict Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624010195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.001005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:03:57Z","timestamp":1739937837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624010195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":104,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0090955624010195"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.001005","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translating Kratom-Drug Interactions: From Bedside to Bench and Back","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.001005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The Author(s)","name":"copyright","label":"Copyright"}]}}